Medix Biochemica appoints IVD industry veteran to board
Medix Biochemica, a leading provider of in vitro diagnostics (IVD) raw materials, has announced the appointment of Lonnie Shoff to its Board of Directors. Shoff, formerly the President of the Clinical Diagnostics Division at Thermo Fisher Scientific, brings over 30 years of international healthcare experience to the role.
Shoff’s career spans multinational corporations including Roche, Thermo Fisher Scientific, and Mars Petcare. Her expertise in corporate strategy, change management, commercial execution, and B2B partnerships is expected to significantly benefit Medix Biochemica’s operations in the IVD industry.
Strategic move for company growth
Ann-Christine Sundell, Chairperson of Medix Biochemica’s Board of Directors, commented on the appointment: “Ms Shoff’s appointment is a continuation in the active development of Medix Biochemica towards our vision to become the most attractive partner for the IVD industry.”
Shoff expressed her enthusiasm: “I am delighted to be joining the Board of Directors of Medix Biochemica. I have long admired the broad offering and stellar quality of the Medix Biochemica portfolio and am honoured to be offered the opportunity to be a part of the company’s exciting future”.
